A detailed history of Gamma Investing LLC transactions in Nanobiotix S.A. stock. As of the latest transaction made, Gamma Investing LLC holds 2,857 shares of NBTX stock, worth $11,170. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,857
Previous 2,030 40.74%
Holding current value
$11,170
Previous $10.2 Million 61.85%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$4.68 - $6.0 $3,870 - $4,962
827 Added 40.74%
2,857 $16.4 Million
Q2 2024

Jul 02, 2024

BUY
$4.16 - $7.31 $3,660 - $6,432
880 Added 76.52%
2,030 $10.2 Million
Q1 2024

Apr 05, 2024

BUY
$6.12 - $8.13 $5,967 - $7,926
975 Added 557.14%
1,150 $7.48 Million
Q4 2023

Feb 01, 2024

BUY
$5.34 - $9.19 $934 - $1,608
175 New
175 $1.33 Million

Others Institutions Holding NBTX

About Nanobiotix S.A.


  • Ticker NBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,875,900
  • Market Cap $136M
  • Description
  • Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...
More about NBTX
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.